期刊文献+

米索前列醇在妇产科临床应用的血药浓度变化研究 被引量:7

原文传递
导出
摘要 米索前列醇是人工合成的一种前列腺素E1类似物,原用于治疗消化性溃疡。由于米索前列醇具有软化宫颈和增强子宫张力及宫内压的作用,现被广泛应用于妇产科领域。米索前列醇的给药途径长期以来以口服为主,效果有限。近年来研究显示米索前列醇其他给药途径(舌下、颊黏膜、阴道以及直肠)在体内的血药浓度变化有差异,且有不同的药效。据此可选择最佳的用药方式应用于妇产科临床各适应证。
出处 《生殖与避孕》 CAS CSCD 北大核心 2010年第3期193-198,共6页 Reproduction and Contraception
  • 相关文献

参考文献33

  • 1Fiala C, Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception. 2006, 74(1): 66-86.
  • 2Karim A. Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile. Prostaglandins, 1987, 33(Suppl):40-50.
  • 3Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol, 1997, 90(1):88-92.
  • 4Tang OS, Schweer H, Seyberth NW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod, 2002, 17(2):332-6.
  • 5Schoenhard G, Oppermann J, Kohn FE. Metabolism and pharmacokinetic studies of misoprostol. Dig Dis Sci, 1985, 30(Suppl 11):126S-128S.
  • 6Khan RU, E1-Refaey H, Sharma S, et al. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol, 2004, 103(SPt 1):866-70.
  • 7Fiala C, Aronsson A, Granath F, et al. Pharmacokinetics of a novel oral slow-release form of misoprostol. Hum Reprod, 2005, 20(12):3414-8.
  • 8Aronsson A, Fiala C, Stephansson O, et al. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublin- gual and slow-release oral misoprostol. Hum Reprod, 2007, 22(7):1912-8.
  • 9Schaff EA, DiCenzo R, Fielding SL Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception, 2005, 71(1):22-5.
  • 10Tang OS, Schweer H, Ho PC, et al. Pharmacokinetics of repeated doses of misoprostol. Hum Reprod, 2009, 24(8): 1862-9.

同被引文献56

  • 1谭海鹰.米索前列醇在妇产科临床的应用[J].中文科技期刊数据库(全文版)医药卫生,2016(7):26-26. 被引量:1
  • 2黄俊,耿琳琳,孟俐,刘静.米索前列醇用于人工流产术前宫颈扩张给药时间的观察[J].中国妇产科临床杂志,2004,5(2):109-112. 被引量:39
  • 3杨琼珍.米非司酮配伍米索前列醇在稽留流产刮宫术前的应用[J].中国计划生育学杂志,2006,14(3):179-180. 被引量:27
  • 4张一琼,陈世彪.米索前列醇对人工流产术中异丙酚使用剂量的影响[J].实用临床医学(江西),2006,7(11):118-120. 被引量:1
  • 5ELATI A, WEEKS A D. The use of misoprostol in obstetrics and gynaecology [ J ]. B JOG,2009,116 ( Supp 1 1 ) :61-69.
  • 6RAJAN P V, WING D A. Postpartum hemorrhage:evidence- based medical interventions for prevention and treatment[ J]. Clin Obstet Gynecol,2010,53( 1 ) : 165-181.
  • 7HOFMEYR G J,GLMEZOGLU A M, NOVIKOV A N,et al. Misoprostol to prevent and treat postpartum haemorrhage:a systematic review and meta-analysis of maternal deaths and dose-related effects [J]. Bull World Health Organ,2009,87 (9) :666-677.
  • 8LANGENBACH C. Misoprostol in preventing postpartum hemorrhage: a meta-analysis [ J ]. Int J Gynaecol Obstet, 2006,92(1) :10-18.
  • 9NASR A, SHAHIN A Y, ELSAMMAN A M, et al. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage [ J ]. Int J Gynaecol Obstet,2009,105 (3) :244-247.
  • 10MECKSTROTH K R, WHITAKER A K, BERTISCH S, et al. Misoprostol administered by epithelial routes:drug absorption and uterine response [ J ]. Obstet Gyneeo1,2006,108 ( 3Pt 1 ) : 582-590.

引证文献7

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部